A study for a 50 year old woman who takes Bisoprolol Fumarate, Levothyroxine Thyroid, Femara, Naturetin-2.5 - from FDA reports


Summary

4 females aged 50 (±5) who take the same drugs are studied. This is a personalized study for a 50 year old female patient who has Low Thyroid, Breast Cancer, High Blood Pressure. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 03, 2017

4 females aged 50 (±5) who take Bisoprolol Fumarate, Levothyroxine Thyroid, Femara, Naturetin-2.5 are studied.


Number of reports submitted per year:

Bisoprolol Fumarate, Levothyroxine Thyroid, Femara, Naturetin-2.5 for a 50-year old woman.

Information of the patient in this study:

  • Age: 50
  • Gender: female
  • Conditions: Low Thyroid, Breast Cancer, High Blood Pressure
  • Drugs taken:
    • Bisoprolol Fumarate (bisoprolol fumarate)
    • Levothyroxine Thyroid (levothyroxine sodium)
    • Femara (letrozole)
    • Naturetin-2.5 (bendroflumethiazide)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Dysuria: 0 (0% of females aged 50 (±5) who take the drugs)
  • Frequent Urination: 0 (0% of females aged 50 (±5) who take the drugs)
  • Frequent Or Urgent Urination: 0 (0% of females aged 50 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

n/a

Top conditions involved for these people *:

  • Breast Cancer Metastatic (2 people, 50.00%)

Top co-used drugs for these people *:

  • Faslodex (3 people, 75.00%)
  • Taxotere (2 people, 50.00%)
  • Taxol (2 people, 50.00%)
  • Kadcyla (2 people, 50.00%)
  • Herceptin (2 people, 50.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Related studies:

Can you answer these questions?

More questions for: Bisoprolol fumarate, Frequent urination, Levothyroxine thyroid, Femara, Naturetin-2.5, Low thyroid, Dysuria, Frequent or urgent urination, Breast cancer, High blood pressure

You may be interested in these reviews

More reviews for: Bisoprolol fumarate, Frequent urination, Levothyroxine thyroid, Femara, Naturetin-2.5, Low thyroid, Dysuria, Frequent or urgent urination, Breast cancer, High blood pressure